Skip to content

Clinical trials

Phase 2 Hemophilia B trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia B Phase: Phase 2 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20091
20152
20171
20181
20193
20201
20232
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated5
Not yet recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ApcinteX Ltd2
Pfizer2
CSL Behring1
Catalyst Biosciences1
Charite University, Berlin, Germany1
Christiana Franke1
Grifols Biologicals, LLC1
IRCCS Policlinico S. Donato1
Novo Nordisk A/S1
PTC Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia B15
Hemophilia A6
Hemorrhage3
Fatigue2
Post-Acute COVID-19 Syndrome2
Afibrinogenemia1
Blood Coagulation Disorders1
Cognition Disorders1
Fatigue Syndrome, Chronic1
Heart Defects, Congenital1

Trials

Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.